Abstract: Efficiently synthesizing an entire application that consists of multiple algorithms for hardware implementation is a very difficult and unsolved problem. One of the main challenges is the ...

Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Cybercriminals have a new, user-friendly tool for turning your browser alerts into a vector for phishing attacks. "Matrix Push" is slick, it's pretty, and it's about as easy to use as any commercial ...

TL;DR: ASUS has officially introduced the Level Sense feature to prevent GPU sag by using sensors to monitor whether the board is sagging in real-time, and warn the owner if this is happening. This ...

BOSTON — A federal judge indicated Thursday she is inclined to take steps to ensure that federal food assistance keeps flowing to 42 million Americans who depend on it. Trump administration officials ...

Come Saturday morning, a new era of Wisconsin high school football will truly begin when the WIAA playoff bracket is released. Unlike in years past, there is a new qualification method called the ...

It all started with an experiment on a domestic cooker… Frustrated by the cost and complexity of producing advanced thermal materials, engineers Danilo Di Salvo and Richard Grainger developed a ...

(RTTNews) - Novavax, Inc. (NVAX) announced Tuesday progress on its collaboration and license agreement (CLA) with Sanofi SA (SNY) regarding Novavax's Matrix-M adjuvant. The companies have amended ...